{"id":164293,"date":"2024-09-12T10:48:15","date_gmt":"2024-09-12T14:48:15","guid":{"rendered":"https:\/\/44.250.171.167\/?p=164293"},"modified":"2024-09-12T10:48:16","modified_gmt":"2024-09-12T14:48:16","slug":"ipca-laboratories-ltd-q1fy25-21-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/ipca-laboratories-ltd-q1fy25-21-rise-in-profits\/","title":{"rendered":"Ipca Laboratories Ltd Q1FY25; 21% rise in Profits"},"content":{"rendered":"\n<p>Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.<\/p>\n\n\n\n<p style=\"font-size:24px\"><strong>Financial Results:<\/strong><\/p>\n\n\n\n<p>Ipca Laboratories Ltd reported Revenues for Q1FY25 of \u20b92,093.00 Crores up from \u20b91,585.00 Crore year on year, a rise of 32.05%.<\/p>\n\n\n\n<p>Total Expenses for Q1FY25 of \u20b91,823.00 Crores up from \u20b91,378.00 Crores year on year, a rise of 32.29%.<\/p>\n\n\n\n<p>Consolidated Net Profit of \u20b9199.00 Crores up 21.34% from \u20b9164.00 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is \u20b97.58, up 18.07% from \u20b96.42 in the same quarter of the previous year.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-34-839x1024.png\" alt=\"\" class=\"wp-image-164294\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-34-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-34-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-34-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-34-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-34.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/figure>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q1FY25 of \u20b92,093.00 Crores up from \u20b91,585.00 Crore year on year, a rise of 32.05%. Total Expenses for Q1FY25 of \u20b91,823.00 Crores up from \u20b91,378.00 Crores year on year, a rise of 32.29%. Consolidated Net Profit [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":164294,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-164293","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-34.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":167062,"url":"https:\/\/alphastreet.com\/india\/ipca-laboratories-ltd-q3fy25-25-rise-in-profits\/","url_meta":{"origin":164293,"position":0},"title":"Ipca Laboratories Ltd Q3FY25; 25% rise in Profits","author":"Chirag Gupta","date":"February 25, 2025","format":false,"excerpt":"Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q3FY25 of \u20b92,245.00 Crores up from \u20b92,053.00 Crore year on year, a rise of 9.35%. Total Expenses for Q3FY25 of \u20b91,897.00 Crores up from \u20b91,855.00 Crores year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/1-15.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":152278,"url":"https:\/\/alphastreet.com\/india\/ipca-laboratories-ltd-q1fy24-13-rise-in-profits\/","url_meta":{"origin":164293,"position":1},"title":"Ipca Laboratories Ltd Q1FY24; 13% rise in Profits","author":"Hardik Bhandare","date":"August 10, 2023","format":false,"excerpt":"Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68) Financial Results: Ipca Laboratories Ltd reported Revenues for Q1FY24 of \u20b91,588.00 Crores up from \u20b91,586.00 Crore year on year, a rise of 0.13%. Total Expenses for Q1FY24 of \u20b91,380.00 Crores down from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-536.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166188,"url":"https:\/\/alphastreet.com\/india\/ipca-laboratories-ltd-q2fy25-81-rise-in-profits\/","url_meta":{"origin":164293,"position":2},"title":"Ipca Laboratories Ltd Q2FY25; 81% rise in Profits","author":"Chirag Gupta","date":"January 3, 2025","format":false,"excerpt":"Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q2FY25 of \u20b92,355.00 Crores up from \u20b92,034.00 Crore year on year, a rise of 15.78%. Total Expenses for Q2FY25 of \u20b92,036.00 Crores up from \u20b91,807.00 Crores year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/download-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/download-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/download-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/download-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/download-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/01\/download-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":162922,"url":"https:\/\/alphastreet.com\/india\/ipca-laboratories-ltd-q4fy24-98-fall-in-profits\/","url_meta":{"origin":164293,"position":3},"title":"Ipca Laboratories Ltd Q4FY24; 98% fall in Profits","author":"Divyansh_Kasana","date":"July 10, 2024","format":false,"excerpt":"Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q4FY24 of \u20b92,033.01 Crores up from \u20b91,511.63 Crore year on year, a rise of 34.49%. Total Expenses for Q4FY24 of \u20b91,838.61 Crores up from \u20b91,418.58 Crores year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-87.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-87.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-87.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-87.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-87.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/07\/image-87.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164227,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q1fy25-21-rise-in-profits\/","url_meta":{"origin":164293,"position":4},"title":"Divis Laboratories Ltd Q1FY25; 21% rise in Profits","author":"Divyansh_Kasana","date":"September 4, 2024","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divis Laboratories Ltd reported Revenues for Q1FY25 of \u20b92,118.00 Crores up from \u20b91,778.00 Crore year on year, a rise of 19.12%. Total Expenses for Q1FY25 of \u20b91,593.00 Crores up from \u20b91,367.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/09\/image-17.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":164086,"url":"https:\/\/alphastreet.com\/india\/alkem-laboratories-ltd-q1fy25-91-rise-in-profits\/","url_meta":{"origin":164293,"position":5},"title":"Alkem Laboratories Ltd Q1FY25; 91% rise in Profits","author":"Divyansh_Kasana","date":"August 26, 2024","format":false,"excerpt":"Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. Financial Results: Alkem Laboratories Ltd reported Revenues for Q1FY25 of \u20b93,032.00 Crores up from \u20b92,968.00 Crore year on year, a rise of 2.16%. Total Expenses\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-172.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-172.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-172.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-172.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-172.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/08\/image-172.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/164293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=164293"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/164293\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/164294"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=164293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=164293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=164293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}